Medirom Healthcare Technologies Return on Equity (ROE) Growth & History (MRM)
Medirom Healthcare Technologies's return on equity was 26.00% for fiscal 2024.
View full Medirom Healthcare Technologies company overviewMedirom Healthcare Technologies annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | 26.00% | −126.34 pp |
| 2023 | 2023-12-31 | 152.35% | — |
| 2021 | 2021-12-31 | −700.38% | −601.57 pp |
| 2020 | 2020-12-31 | −98.81% | — |
Medirom Healthcare Technologies return on equity trends
Between the periods ended 2020-12-31 and 2024-12-31, Medirom Healthcare Technologies's return on equity increased from −98.81% to 26.00%, a change of +124.82 percentage points.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medirom Healthcare Technologies source filings ↗